DexCom Schedules Conference Call to Discuss Approval and Launch of Its Recently Approved 7-Day STS(R) Continuous Glucose Monitoring System

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will hold a conference call to discuss the approval and launch of the SEVEN™ Continuous Glucose Monitoring System. The call will occur on Monday, June 11, 2007 at 1:30 pm (PDT).

MORE ON THIS TOPIC